Purchase Order 75N91020P00194

<p>The National Cancer Institute awarded a purchase order to Tecan U.S., Inc. for $24,648.37 on May 6, 2019, with a completion date of May 5, 2020. The order is for a new plate reader to support service to new employees. Place of performance is Morrisville, North Carolina. Pricing is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Tecan U.S., Inc. valued at $77,424.26 on September 9, 2016, for a SPARK 20M plate reader. Performance is located in Morrisville, North Carolina. The order carries no set-aside designation and represents a de-obligation of expiring FY2016 funds. The award is firm fixed price with an ultimate completion date of October 24, 2016.</p>

The National Cancer Institute (NCI), under the National Institutes of Health (NIH), awarded a $34,867.23 firm fixed-price purchase order to Tecan U.S., Inc. for the acquisition of one Tecan Spark Cyto multi-mode plate reader with NanoQuant plate. The award, issued on June 7, 2021, with an ultimate completion date of June 9, 2022, supports research operations at the NCI's Center for Cancer Research in Morrisville, North Carolina. This procurement utilized no set-aside designation, allowing...

<p>The National Cancer Institute awarded a purchase order to Tecan U.S., Inc. for $7,878.00 on March 8, 2018, with an ultimate completion date of March 7, 2019. The order is fixed-price with economic price adjustment and carries no set-aside. Work is performed in Bethesda, Maryland. The purchase order covers laboratory automation equipment or related maintenance services typical of Tecan's OEM product line, delivered to the National Cancer Institute's facilities.</p>

<p>The National Cancer Institute issued a purchase order to Tecan U.S., Inc. on August 16, 2016, valued at $3,604.93 for firm fixed price, with an ultimate completion date of May 23, 2021. The order represents a de-obligation of funds from expiring FY2016 lines with no set-aside. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute issued a purchase order to Tecan U.S., Inc. valued at $4,793.91, awarded August 24, 2017, with an ultimate completion date of October 30, 2017. The order is for Tecan and lab supplies, to be performed in Morrisville, North Carolina. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Tecan U.S., Inc. valued at $5,400.64 on January 3, 2019, with completion scheduled for January 30, 2020. No set-aside was used. Performance is located in San Diego, California. The order is firm fixed price for laboratory automation equipment or services; specific line items are not detailed in the source.</p>

<p>The National Cancer Institute issued a purchase order to Tecan U.S., Inc. for $6,250 on September 1, 2013, covering preventive maintenance parts and labor for a Tecan robot under a complete preventive maintenance agreement, with performance in Switzerland and completion by August 31, 2014.</p>

This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders to Tecan U.S., Inc. (Tecan) for the purchase of a Tecan Spark microplate reader. The contract is a firm fixed price purchase order with a potential value of $24,991.23 and a completion date of March 20, 2025. Tecan, a Switzerland-based manufacturer and distributor of laboratory automation solutions, has provided...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Tecan U.S., Inc. for $29,633.32 on August 9, 2021, to procure a Spark microplate reader for the National Human Genome Research Institute's Center for Common Disease Genetics. Performance is located in Morrisville, North Carolina. The order is firm fixed price with an ultimate completion date of July 31, 2022. No set-aside was used. The solicitation was posted July 27, 2021, with a due date of August 5, 2021.</p>